AuKing Mining Ltd (ASX:AKN) has secured binding commitments from sophisticated and professional investors to raise A$1.5 million (before costs) via an unbrokered share placement.
Funds from the placement will be used to advance exploration programs, provide flexibility to assess and pursue strategic opportunities, support working capital, and cover placement costs.
Memory has quietly become one of the most important cost pressures in the tech supply chain — and this week, that pressure acquired a longer time horizon.
US chipmaker Micron Technology Inc (NASDAQ:MU) warned that tight global supply of dynamic random access memory (DRAM), the core RAM used in PCs, smartphones and servers, is unlikely to ease in any meaningful way before 2028. The company said that even with new factories under construction, supply is unlikely to catch up with demand any time soon.
China posted a record trade surplus of about $US1.2 trillion in 2025, as a late-year lift in outbound shipments capped another year where exports did the heavy lifting for the world’s No. 2 economy.
Fresh figures from the General Administration of Customs showed December exports rose 6.6% year-on-year, beating market expectations for a much smaller gain and marking the strongest pace in 3 months. Imports also surprised to the upside, up 5.7% from a year earlier.
BTC Markets head of finance Charlie Sherry says bitcoin’s 4%–5% intraday bounce points to improving macro conditions, renewed institutional inflows and constructive regulatory signals.
The move briefly lifted the cryptocurrency above US$96,000 before it eased to about US$95,500, breaking out of a US$92,000–US$94,000 trading range.
Neuren Pharmaceuticals Ltd (ASX:NEU) partner Acadia Pharmaceuticals expects global net sales of DAYBUE to reach approximately US$700 million in 2028, underpinned by new product formats, expanding patient uptake in the United States and international market growth.
The update follows Acadia’s presentation at the 44th annual J.P. Morgan Healthcare Conference, where the US-based company outlined its medium-term commercial outlook for DAYBUE (trofinetide), which is approved by the US Food and Drug Administration for the treatment of Rett syndrome.
Rumble Resources Ltd (ASX:RTR, OTC:RTRFF) has reported a series of high-grade gold intercepts from ongoing diamond drilling at its Western Queen project in Western Australia, highlighted by a standout hit of more than 30 grams per tonne gold beneath historical underground workings.
The latest results come from the company’s 20,000-metre drilling campaign, which resumed this month following the Christmas and New Year break and is aimed at extending and upgrading the existing gold and tungsten resources at the project.
Auric Mining Ltd (ASX:AWJ) is edging closer to near-term gold cashflows, with mining and haulage now under way at its Munda Gold Mine and toll treatment scheduled to begin later this month.
In an operational update released on Wednesday, Auric said it had built up about 67,000 tonnes of high-grade ore on run-of-mine (ROM) stockpiles at Munda as of December 31, 2025, providing the foundation for its next toll processing campaign.
Atomic Eagle Ltd (ASX:AEU) has completed its maiden drill program at the high-priority Chisebuka target within its Muntanga Uranium Project in Zambia, with final results continuing to confirm broad, near-surface uranium mineralisation suited to bulk open-pit development.
The 69-hole program — the first drilling at Chisebuka in 15 years — has consistently returned thick intersections at shallow depths, reinforcing the company’s geological model and providing a platform for further resource growth across the broader Muntanga licence area.
Assays from Terra Metals Ltd (ASX:TM1)'s SW5 target have delivered a second platinum group metal (PGM)-copper-nickel sulfide discovery at the Southwest Prospect within the Dante Project, adding to the earlier SW6 find and pointing to multiple mineralised positions across the broader Southwest area.
The company said first drillhole SWT011 returned a 69m continuously mineralised interval from 48m grading 0.92g/t PGE3, with several higher-grade zones and associated copper and nickel.
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has received an A$5,339,202 cash refund from the Australian Taxation Office under the Research and Development (R&D) Tax Incentive for the financial year ended June 30, 2025.
The payment relates to eligible R&D activities undertaken both in Australia and offshore, and was received in cash.
Pantoro Gold Ltd (ASX:PNR, OTC:PNTOF) has reported a fresh set of high-grade drilling results from the Daisy South deposit at its 100%-owned Norseman Gold Project in Western Australia, confirming extensions to mineralisation and strengthening the case for a new open pit to be developed alongside existing operations.
Results from ongoing surface drilling at Daisy South include both infill and step-out intercepts, with the company saying the latest data supports its current mineralisation model and feeds directly into updated open pit mine design and planning work.
Altech Batteries Ltd (ASX:ATC, OTC:ALTHF) is relocating its Silumina Anodes™ research and development laboratory from Perth to Germany, aligning it with the Silumina Anodes™ pilot plant in Saxony.
The pilot plant has been constructed and is operating at the Saxony site, with the co-location of the laboratory and pilot facility expected to improve R&D testwork, support pilot plant operations and deliver cost efficiencies.